Chiral N-substituted allylic amine compounds
US-10179330-B2 · Jan 15, 2019 · US
US11021494B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11021494-B2 |
| Application number | US-201816211806-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2018 |
| Priority date | Mar 27, 2017 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafine, Naftifine 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivastigmine. There are over 20,000 known bioactive molecules with chiral N-substituted allylic amine substructure. The method may also be used to produce non-natural chiral 13-aminoacid esters, a sub-class of chiral N-substituted allylic amine compounds. Examples of 13-aminoacid ester which can be produced by the disclosed method, include, but are not limited to, N-(2-methylpent-1-en-3-yl)benzenamine and Ethyl 2-methylene-3-(phenylamino)butanoate. Further, the products of the method described herein can be used to produce chiral heterocycles and bioactive molecules or materials. A novel chiral copper-BINAM nitrosoarene complex is also set forth.
Opening claim text (preview).
The invention claimed is: 1. An isolated chemical compound comprising: a. a copper atom; b. two nitrosoarenes; c. two nitrogen donor ligands; and d. two counterions. 2. The isolated chemical compound of claim 1 wherein the compound is a chiral coppernitrosoarene complex. 3. The isolated chemical compound of claim 1 wherein at least one ligand is chiral. 4. The isolated chemical compound of claim 1 wherein the copper atom is bonded to two chiral nitrogen-donor ligands. 5. The isolated chemical compound of claim 4 wherein the chiral nitrogen-donor ligands are selected from the group comprising BINAM and NOBIN. 6. The isolated chemical compound of claim 1 wherein the copper atom is bonded to two nitrosoarenes. 7. The isolated chemical compound of claim 6 wherein the nitrosoarenes consist of nitrosobenzene. 8. The isolated chemical compound of claim 1 wherein the copper complex is associated with at least one counter ion. 9. The isolated chemical compound of claim 8 wherein the at least one counter ion is selected from the group comprising triflates and halides.
the ligands containing nitrogen · CPC title
Oxygen, e.g. acetylacetonates · CPC title
without C-Metal linkages · CPC title
Copper compounds · CPC title
Hydroformylation, metalformylation, carbonylation or hydroaminomethylation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.